InsiderClue
← All stocks

Inhibikase Therapeutics, Inc.

IKT Net buying
CIK 0001750149 #3494 in the set updated 18 Sep 2026
Bought (120 mo)
$5.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$5.76M
+$5.76M against sales at will

By person

10 insiders · 18 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sands Capital Life Sciences Pulse Fund II, L.P. entity
10% owner
$3.00M (1)
—
+$3.00M
13,018,965
$18.88M
+18.9%
Bellini Roberto
Director
$2.00M (1)
—
+$2.00M
1,460,000
$2.12M
—
Munshi Amit
Director
$500.05K (1)
—
+$500.05K
403,176
$584.61K
—
Kush Arvind
Director
$198.65K (1)
—
+$198.65K
145,000
$210.25K
—
Werner Milton H.
President and CEO
$61.44K (8)
—
+$61.44K
5,359,022
$7.77M
+2.2%
FRATTAROLI JOSEPH
Cheif Financial Officer
$2.54K (1)
—
+$2.54K
92,234
$133.74K
+108.9%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
—
—
—
6,970,000
$10.11M
−72.1%
Cabell Christopher
President & Head of R&D
—
—
—
676,564
$981.02K
−33.3%
Aurentz Vincent
Director
—
—
—
510,596
$740.36K
−33.3%
BERMAN DENNIS N
Director
—
—
—
21,854
$31.69K
—

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 67,192,570 to 139,535,900 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
BERMAN DENNIS N
30 Jul 2026
Director
Exercised, kept
21,854
$1.26
$27.54K
Sands Capital Life Sciences Pulse Fund II, L.P.
21 Nov 2025
10% owner
Buy
2,068,965
$1.45
$3.00M
Munshi Amit
21 Oct 2024
Director
Buy indirect
365,000
$1.37
$500.05K
Kush Arvind
21 Oct 2024
Director
Buy
145,000
$1.37
$198.65K
Bellini Roberto
21 Oct 2024
Director
Buy indirect
1,460,000
$1.37
$2.00M
Werner Milton H.
16 Aug 2022
President and CEO
Buy
5,000
$0.80
$4.00K
Werner Milton H.
27 May 2022
President and CEO
Buy
5,000
$0.98
$4.88K
Werner Milton H.
20 May 2022
President and CEO
Buy
10,000
$0.60
$6.00K
FRATTAROLI JOSEPH
19 May 2022
Chief Financial Officer
Buy
3,948
$0.64
$2.54K
Werner Milton H.
3 Jan 2022
President and CEO
Exercised, kept
21,853
$2.02
$44.14K
Werner Milton H.
17 Nov 2021
President and CEO
Buy indirect
400
$1.93
$772.00
Werner Milton H.
17 Nov 2021
President and CEO
Buy indirect
1,334
$1.94
$2.59K
Werner Milton H.
17 Nov 2021
President and CEO
Buy indirect
3,186
$1.96
$6.24K
Werner Milton H.
17 Nov 2021
President and CEO
Buy indirect
1,100
$1.97
$2.17K
Werner Milton H.
17 Nov 2021
President and CEO
Buy indirect
17,569
$1.98
$34.79K
Werner Milton H.
17 Aug 2021
President and CEO
Exercised, kept
21,853
$2.02
$44.14K
Werner Milton H.
14 May 2021
President and CEO
Exercised, kept
43,707
$0.38
$16.61K
FRATTAROLI JOSEPH
28 Dec 2020
Chief Financial Officer
Exercised, kept indirect
44,143
$10.00
$441.43K

What was left out

Form 4 filings counted 84
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 18,870,263
History held since 29 Dec 2020